Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
- Ian W. Flinn
- , Brad S. Kahl
- , John P. Leonard
- , Richard R. Furman
- , Jennifer R. Brown
- , John C. Byrd
- , Nina D. Wagner-Johnston
- , Steve E. Coutre
- , Don M. Benson
- , Sissy Peterman
- , Yoonjin Cho
- , Heather K. Webb
- , David M. Johnson
- , Albert S. Yu
- , Roger G. Ulrich
- , Wayne R. Godfrey
- , Langdon L. Miller
- , Stephen E. Spurgeon
Research output: Contribution to journal › Article › peer-review
203
Link opens in a new tab
Scopus
citations